Matches in Wikidata for { <http://www.wikidata.org/entity/Q58763997> ?p ?o ?g. }
- Q58763997 description "article" @default.
- Q58763997 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58763997 description "wetenschappelijk artikel" @default.
- Q58763997 description "наукова стаття, опублікована в грудні 2018" @default.
- Q58763997 name "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 name "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 type Item @default.
- Q58763997 label "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 label "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 prefLabel "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 prefLabel "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 P1433 Q58763997-790BA9B5-0470-4790-BAAF-5480F0B37CDD @default.
- Q58763997 P1476 Q58763997-6A36766D-80BB-4C66-9154-8A6241017F19 @default.
- Q58763997 P2093 Q58763997-330D182C-3DED-4305-A571-8DA7AACF8152 @default.
- Q58763997 P2093 Q58763997-3A949434-1AE8-4455-BA17-B12FE4EC9AD0 @default.
- Q58763997 P2093 Q58763997-40179A29-8709-40CD-9E5E-5181C2AD74DA @default.
- Q58763997 P2093 Q58763997-56F7C6F8-286F-4A76-A570-B116CD120131 @default.
- Q58763997 P2093 Q58763997-7F86BCE8-4D6B-40F5-A4D6-A4273F38A3DC @default.
- Q58763997 P2093 Q58763997-C91A3887-6AB3-4BA7-A0FB-A8F7F68930A8 @default.
- Q58763997 P2093 Q58763997-D5BBF183-292A-4F22-B2A9-C18ABCDA24EB @default.
- Q58763997 P2093 Q58763997-F6A23F5F-7E03-4299-BEA7-9C6E2DA5CA17 @default.
- Q58763997 P275 Q58763997-b915df90-2447-4505-850a-67bd42391ba3 @default.
- Q58763997 P2860 Q58763997-0156589D-0FE3-4E18-84C1-2C17FF22548D @default.
- Q58763997 P2860 Q58763997-169CA7D7-952D-4E31-8AFA-3140497D8BFD @default.
- Q58763997 P2860 Q58763997-1FDF7B11-7C8B-4073-BC12-08A794A91F90 @default.
- Q58763997 P2860 Q58763997-24AEEEF4-ACCA-4B19-9A7B-008F6BF257E5 @default.
- Q58763997 P2860 Q58763997-308777E2-4F70-4641-A3AC-6D503C816B76 @default.
- Q58763997 P2860 Q58763997-49F5E2E5-83B8-44F5-89B9-BB95CDDCD698 @default.
- Q58763997 P2860 Q58763997-56E122D0-D9D5-4728-A577-7689B0125E65 @default.
- Q58763997 P2860 Q58763997-5CD03A6D-86DB-4565-94CE-E678542ED684 @default.
- Q58763997 P2860 Q58763997-6292B7EE-9D97-458C-84A5-11667DDF4E8E @default.
- Q58763997 P2860 Q58763997-66D850A2-9F9C-442C-9B73-D7324B217CFC @default.
- Q58763997 P2860 Q58763997-6900855E-CE45-451B-A3D8-201089E85C5C @default.
- Q58763997 P2860 Q58763997-6AEFF5BC-1600-4B99-98B4-CFF7F46D22F2 @default.
- Q58763997 P2860 Q58763997-6B4DCF10-463B-49BA-B82A-1BF0CD7E7B9E @default.
- Q58763997 P2860 Q58763997-6BE06FE1-C101-45E1-99AF-91A9C8396D63 @default.
- Q58763997 P2860 Q58763997-6D1E5B85-02F6-4ABC-8FA9-31686ED50E5B @default.
- Q58763997 P2860 Q58763997-6E6E6C69-B452-4C68-AC50-A78AD5D651C9 @default.
- Q58763997 P2860 Q58763997-955C8936-5566-41AD-934A-A945A00BB576 @default.
- Q58763997 P2860 Q58763997-99E48858-7D7B-4EB5-9316-7BA380900FDE @default.
- Q58763997 P2860 Q58763997-A02DA356-669F-4BE7-939E-D713D1EE7ACE @default.
- Q58763997 P2860 Q58763997-A1604540-16B7-4641-9C53-8E8A21029E0F @default.
- Q58763997 P2860 Q58763997-A422009E-2226-4B8B-8C0E-4D34ECB78E40 @default.
- Q58763997 P2860 Q58763997-A814C03F-B3A4-476B-93A3-2B4E2D94FF34 @default.
- Q58763997 P2860 Q58763997-B017B9A2-3795-4D20-8B5A-B7EAF5845E12 @default.
- Q58763997 P2860 Q58763997-BC87EC9A-DA9F-442F-B7A8-331CB5B92C35 @default.
- Q58763997 P2860 Q58763997-BFEA44C7-D935-4DA6-BE6A-127C10F4850D @default.
- Q58763997 P2860 Q58763997-C610612A-6015-48C5-8E2E-1FF20FA85945 @default.
- Q58763997 P2860 Q58763997-CC84D012-AEB1-4A51-BF42-E6758A107639 @default.
- Q58763997 P2860 Q58763997-DAA64BF0-4B95-4326-AAA1-EC5D6C2412F2 @default.
- Q58763997 P2860 Q58763997-DD1A32CB-201A-4083-8CDE-506FA4FC27A3 @default.
- Q58763997 P2860 Q58763997-E35F8EAB-ED47-4A49-A458-78BAFDD24C4C @default.
- Q58763997 P2860 Q58763997-E46278AF-312E-4CC9-8378-EC2C17F560FD @default.
- Q58763997 P2860 Q58763997-EF4A34B6-95D8-4480-9958-D28AA6E613BB @default.
- Q58763997 P2860 Q58763997-F467AB30-632E-4E60-9450-8FA464171F32 @default.
- Q58763997 P2860 Q58763997-F59C22F8-A88C-48CE-B185-E2D235795F61 @default.
- Q58763997 P304 Q58763997-BCBBB482-B63E-43BC-9AC8-8902040C6DDC @default.
- Q58763997 P31 Q58763997-B5E0EAEB-B18C-41DB-9D73-2B65FCAB9362 @default.
- Q58763997 P356 Q58763997-FE639E3C-5122-4606-B1F8-42149A4448A0 @default.
- Q58763997 P407 Q58763997-E80AFA0C-7275-47CF-A284-663C4B9E8BDC @default.
- Q58763997 P433 Q58763997-A33F8B73-6508-4506-9540-D64BA1B13649 @default.
- Q58763997 P478 Q58763997-9F6286FE-E9BB-4079-B897-D0EED1D74DCC @default.
- Q58763997 P577 Q58763997-D3808AEB-52FA-4D47-9DBD-B4C73537D21A @default.
- Q58763997 P6216 Q58763997-a0266cb2-0378-4e5a-a402-33d6ff572e57 @default.
- Q58763997 P698 Q58763997-FADF385E-96EC-4E34-B0FE-C8B8634AF578 @default.
- Q58763997 P921 Q58763997-60C48F9C-BC2C-40B2-85FC-0E53DFAD8052 @default.
- Q58763997 P921 Q58763997-801E29B1-B90F-404A-BD53-3BAE24CA5977 @default.
- Q58763997 P921 Q58763997-85A960A0-1645-4D00-909A-85633EA34E90 @default.
- Q58763997 P932 Q58763997-FFC05F4C-B618-4A69-B8E6-100C9527A53D @default.
- Q58763997 P356 S00277-018-3469-4 @default.
- Q58763997 P698 30178193 @default.
- Q58763997 P1433 Q15766509 @default.
- Q58763997 P1476 "Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study" @default.
- Q58763997 P2093 "Abderrahim Oukessou" @default.
- Q58763997 P2093 "Amber Kudlac" @default.
- Q58763997 P2093 "Antonio Palumbo" @default.
- Q58763997 P2093 "Catherine Davis" @default.
- Q58763997 P2093 "David Cella" @default.
- Q58763997 P2093 "Jan McKendrick" @default.
- Q58763997 P2093 "Ravi Vij" @default.
- Q58763997 P2093 "Teresa Zyczynski" @default.
- Q58763997 P275 Q20007257 @default.
- Q58763997 P2860 Q33377526 @default.
- Q58763997 P2860 Q34067762 @default.
- Q58763997 P2860 Q34114747 @default.
- Q58763997 P2860 Q34515517 @default.
- Q58763997 P2860 Q34549410 @default.
- Q58763997 P2860 Q34656801 @default.
- Q58763997 P2860 Q34753416 @default.
- Q58763997 P2860 Q35045634 @default.
- Q58763997 P2860 Q36286862 @default.
- Q58763997 P2860 Q37240851 @default.
- Q58763997 P2860 Q37363465 @default.
- Q58763997 P2860 Q37403763 @default.
- Q58763997 P2860 Q37440614 @default.
- Q58763997 P2860 Q37811674 @default.
- Q58763997 P2860 Q38004979 @default.
- Q58763997 P2860 Q38459634 @default.
- Q58763997 P2860 Q38693312 @default.
- Q58763997 P2860 Q39416134 @default.